Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Samen Pharmaceutical Co., also known as Samen Darou, is a leading Iranian pharmaceutical company based in Mashhad. Established in 1984, it specializes in the production of large-volume and small-volume parenterals, as well as specialized ophthalmic products. The company is notably the sole producer of peritoneal dialysis solutions in Iran and has successfully ventured into biotechnology. Its flagship biotech product, Safacto, is a recombinant human Coagulation Factor VIII used for treating Hemophilia A. Samen Pharmaceutical operates extensive manufacturing facilities that adhere to international GMP standards, serving both the domestic Iranian market and various export destinations in the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Samen Pharmaceutical.